Adagio Therapeutics Aktie
WKN DE: A3CWUU / ISIN: US00534A1025
20.03.2025 13:11:35
|
Invivyd, Inc. Full Year Loss Decreases, But Misses Estimates
(RTTNews) - Invivyd, Inc. (IVVD) announced Loss for full year that decreased from the same period last year but missed the Street estimates.
The company's bottom line totaled -$169.93 million, or -$1.43 per share. This compares with -$198.64 million, or -$1.81 per share, last year.
Analysts on average had expected the company to earn -$1.38 per share. Analysts' estimates typically exclude special items.
Invivyd, Inc. earnings at a glance (GAAP) :
-Earnings: -$169.93 Mln. vs. -$198.64 Mln. last year. -EPS: -$1.43 vs. -$1.81 last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Adagio Therapeutics Inc Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Adagio Therapeutics Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
Adagio Therapeutics Inc Registered Shs | 0,55 | 8,71% |
|